Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab

Publication date: Available online 11 December 2017
Source:European Journal of Cancer
Author(s): Max Rogatsch, Johannes Schmid, Sigurd Lax, Maximilian Uranitsch, Karin Schmid-Zalaudek, Roberta Giuffrida, Iris Zalaudek




from Cancer via ola Kala on Inoreader http://ift.tt/2AaYoKH
via IFTTT